Yinnian Feng

Vanderbilt engineers have made a significant leap toward developing killer T cells to attack cancer tumors by “nudging” them into action with far less evidence of disease than previously thought. Now, researchers will look for T cells that demonstrate potential for the strongest binding when they’re flung at damaged cells. Read More